Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
vedolizumab (entyvio) (1 trial)
Celiac Disease (Phase 2)
Enteritis (Phase 2)
Trials (1 total)
Trial APIs (1 total)